PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Garz, A.-K.* ; Weickert, M.-T.* ; Pagel, C.* ; Habringer, S.* ; Vick, B. ; Jeremias, I. ; Keller, U.* ; Oostendorp, R.* ; Peschel, C.* ; Goetze, K.*

The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.

Oncol. Res. Treat. 38, 214 (2015)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2015
HGF-reported in Year 0
ISSN (print) / ISBN 2296-5270
e-ISSN 2296-5262
Journal Oncology Research and Treatment
Quellenangaben Volume: 38, Issue: , Pages: 214 Article Number: , Supplement: ,
Publisher Karger
Reviewing status Peer reviewed
Institute(s) Research Unit Gene Vector (AGV)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-501590-001
WOS ID WOS:000364268800515
Erfassungsdatum 2015-12-08
[➜Report correction]